Directed Evolution of a Mycobacteriophage
AbstractBacteriophages represent an alternative strategy to combat pathogenic bacteria. Currently, Mycobacterium tuberculosis infections constitute a major public health problem due to extensive antibiotic resistance in some strains. Using a non-pathogenic species of the same genus as an experimental model, Mycobacterium smegmatis, here we have set up a basic methodology for mycobacteriophage growth and we have explored directed evolution as a tool for increasing phage infectivity and lytic activity. We demonstrate mycobacteriophage adaptation to its host under different conditions. Directed evolution could be used for the development of future phage therapy applications against mycobacteria. View Full-Text
Share & Cite This Article
Cebriá-Mendoza, M.; Sanjuán, R.; Domingo-Calap, P. Directed Evolution of a Mycobacteriophage. Antibiotics 2019, 8, 46.
Cebriá-Mendoza M, Sanjuán R, Domingo-Calap P. Directed Evolution of a Mycobacteriophage. Antibiotics. 2019; 8(2):46.Chicago/Turabian Style
Cebriá-Mendoza, María; Sanjuán, Rafael; Domingo-Calap, Pilar. 2019. "Directed Evolution of a Mycobacteriophage." Antibiotics 8, no. 2: 46.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.